HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors

Clinical trial NCT05124743 · TERMINATED

Trial details

NCT number: NCT05124743
Sponsor: Alaunos Therapeutics
Status: TERMINATED
Study type: OBSERVATIONAL

Ovarian Cancer Endometrial Cancer Colo-rectal Cancer Cholangiocarcinoma Non-small Cell Lung Cancer Pancreas Cancer

Start date: 2021-09-24
Primary completion: 2023-08-14
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.